Abstract
Objective: To evaluate the use of aerosolized magnesium sulfate (MgSO4) in combination with inhaled betaagonists compared to inhaled beta-agonists alone in the treatment of acute asthma. Methods: Published (1966-2005) randomized controlled trials were retrieved using different databases, bibliographic reviews of primary research, review articles, and citations from texts. The primary outcome measure was pulmonary function. Results: Five out of 16 potentially eligible studies met criteria for inclusion in the meta-analysis. They included 187 adults and 62 children who were treated in an emergency department. Patients that received MgSO4 showed non-significant improvement in pulmonary function (SMD = -0.21, 95%CI:-0.52 to 0.10, p = 0.18). The advantage of the use of MgSO4 was demonstrated only in patients with life-threatening acute asthma (baseline FEV1 or PEF < 30% predicted) (SMD = - 1.10; 95%CI: -1.80 to -0.39, p = 0.002; I2 = 0%). Nebulized MgSO4 with beta-agonists showed a marginal significant reduction in admission rate compared to beta-agonists alone (RR = 0.63, 95% CI: 0.39 to 1.01, p = 0.06, I2 = 0%). Conclusions: Data suggests that MgSO4 presents a beneficial effect in terms of pulmonary function only in the subgroup of life-threatening acute asthma patients. However, the small number of studies selected, the standard treatment used in all trials, and the beta-agonist delivery method restricts this conclusion.
Keywords: Magnesium sulphate, beta-agonists, acute severe asthma, emergency department treatment
Current Drug Therapy
Title: Is There a Place for Nebulized Magnesium Sulfate in the Treatment of Acute Asthma? A Systematic Review
Volume: 1 Issue: 2
Author(s): Gustavo J. Rodrigo and Luis J. Nannini
Affiliation:
Keywords: Magnesium sulphate, beta-agonists, acute severe asthma, emergency department treatment
Abstract: Objective: To evaluate the use of aerosolized magnesium sulfate (MgSO4) in combination with inhaled betaagonists compared to inhaled beta-agonists alone in the treatment of acute asthma. Methods: Published (1966-2005) randomized controlled trials were retrieved using different databases, bibliographic reviews of primary research, review articles, and citations from texts. The primary outcome measure was pulmonary function. Results: Five out of 16 potentially eligible studies met criteria for inclusion in the meta-analysis. They included 187 adults and 62 children who were treated in an emergency department. Patients that received MgSO4 showed non-significant improvement in pulmonary function (SMD = -0.21, 95%CI:-0.52 to 0.10, p = 0.18). The advantage of the use of MgSO4 was demonstrated only in patients with life-threatening acute asthma (baseline FEV1 or PEF < 30% predicted) (SMD = - 1.10; 95%CI: -1.80 to -0.39, p = 0.002; I2 = 0%). Nebulized MgSO4 with beta-agonists showed a marginal significant reduction in admission rate compared to beta-agonists alone (RR = 0.63, 95% CI: 0.39 to 1.01, p = 0.06, I2 = 0%). Conclusions: Data suggests that MgSO4 presents a beneficial effect in terms of pulmonary function only in the subgroup of life-threatening acute asthma patients. However, the small number of studies selected, the standard treatment used in all trials, and the beta-agonist delivery method restricts this conclusion.
Export Options
About this article
Cite this article as:
Rodrigo J. Gustavo and Nannini J. Luis, Is There a Place for Nebulized Magnesium Sulfate in the Treatment of Acute Asthma? A Systematic Review, Current Drug Therapy 2006; 1 (2) . https://dx.doi.org/10.2174/157488506776931003
DOI https://dx.doi.org/10.2174/157488506776931003 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
Call for Papers in Thematic Issues
Novel Therapeutic Approaches and Biomarkers for Chronic Kidney Disease (CKD)
The thematic issue on "Novel Therapeutic Approaches and Biomarkers for CKD" aims to provide a comprehensive exploration of cutting-edge strategies for the management of chronic kidney disease (CKD). This issue will delve into emerging therapeutic targets, focusing on critical aspects such as podocyte injury, endothelial dysfunction, and tubulointerstitial fibrosis, which ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Meet Our Editorial Board Member
Recent Patents on Inflammation & Allergy Drug Discovery Cytochrome P450 Regulation and Drug Biotransformation During Inflammation and Infection
Current Drug Metabolism Relations between GPR4 Expression, Microvascular Density (MVD) and Clinical Pathological Characteristics of Patients with Epithelial Ovarian Carcinoma (EOC)
Current Pharmaceutical Design Chemistry and Pharmacology of Deflazacort: A Novel Bioactive Compound for the Treatment of Duchenne Muscular Dystrophy-A Mini Review
Current Bioactive Compounds Addressing Unmet Medical Needs in Type 2 Diabetes: A Narrative Review of Drugs under Development
Current Diabetes Reviews The Endothelin Axis: A Novel Target for Pharmacotherapy of Female Malignancies
Current Vascular Pharmacology Potential Role of Rho Kinase Inhibitors in Combating Diabetes-Related Complications Including Diabetic Neuropathy-A Review
Current Diabetes Reviews Neutrophil Proteome: Lessons from Different Standpoints
Protein & Peptide Letters The Guinea Pig as an Animal Model for Asthma
Current Drug Targets Heparin - a Key Drug in the Treatment of the Circulatory Degenerative Diseases: Controlling its Action with Polymers
Current Pharmaceutical Design Role of Chemical Reactivity and Transition State Modeling for Virtual Screening
Combinatorial Chemistry & High Throughput Screening Novel Strategies for the Treatment of Asthma
Recent Patents on Inflammation & Allergy Drug Discovery Molecular and Epigenetic Basis of Extracellular Vesicles Cell Repair Phenotypes in Targeted Organ-specific Regeneration
Current Molecular Medicine <i>Fagonia indica</i>; A Review on Chemical Constituents, Traditional Uses and Pharmacological Activities
Current Pharmaceutical Design TGF-β: Its Role in Asthma and Therapeutic Potential
Current Drug Targets Overlap Syndrome of Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea: A Two-Faced Janus
Current Respiratory Medicine Reviews SARS-CoV-2 Transmission Among Healthcare Workers in Iran: An Urgent Need for Early Identification and Management
Infectious Disorders - Drug Targets The Emerging Role of the Histamine H4 Receptor in Anti-inflammatory Therapy
Current Topics in Medicinal Chemistry The Need to Consider Context in the Evaluation of Anti-infectious and Immunomodulatory Effects of Vitamin A and its Derivatives
Current Drug Targets Chemokines in Allergy
Current Drug Targets - Inflammation & Allergy